
DCC-3116 (DCC3116) is a first-in-class, селективный ингибитор of ULK1/2 kinases (IC50=4.7/35 nM) and autophagy.DCC-3116 is an oral ULK1/2 ингибитор targeting the autophagy pathway, a key mechanism of tumor survival and resistance to targeted therapy.
DCC-3116 (DCC3116) is a first-in-class, selective inhibitor of ULK1/2 kinases (IC50=4.7/35 nM) and autophagy.DCC-3116 is an oral ULK1/2 inhibitor targeting the autophagy pathway, a key mechanism of tumor survival and resistance to targeted therapy.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.